A Massachusetts-based pharmaceutical company announced it signed an agreement to acquire Rockville biotechnology firm Vigene Biosciences, Inc. on Research Court. Charles River Laboratories International, Inc. said it expects to purchase Vigene Biosciences for $292.5 million, subject to some adjustments. The purchase includes contingent future payments of up to $57.5 million based on performance, according to […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia